Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe

Diagnostic Molecular Pathology

Volumn 14, Issue 2, 2005, Pages 77-82

  Terry, Jefferson ^a   Barry, Todd S ^b   Horsman, Douglas E ^a   Hsu, Forrest D ^a   Gown, Allen M ^b   Huntsman, David G ^a   Nielsen, Torsten O ^a,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b PHENOPATH LABORATORIES   (United States)

^c Anatomical Pathology   (Canada)

Author keywords

CISH; Diagnosis; FISH; Synovial sarcoma; Tissue microarray

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CHROMOGENIC IN SITU HYBRIDIZATION; CHROMOSOME 18; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DISRUPTION; GENE PROBE; GENE TRANSLOCATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KARYOTYPE; PRIORITY JOURNAL; SYNOVIAL SARCOMA; TISSUE MICROARRAY;

CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 18; DNA, COMPLEMENTARY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID PROBES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SARCOMA, SYNOVIAL; SEQUENCE DELETION; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC;

EID: 19544371756     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000155021.80213.c9     Document Type: Article

References (41)

1. Fisher C. Synovial sarcoma. Ann Diagn Pathol. 1998;2:401-421.
2. dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer. 2001;30:1-14.
3. de Silva MV, McMahon AD, Paterson L, et al. Identification of poorly differentiated synovial sarcoma: A comparison of clinicopathological and cytogenetic features with those of typical synovial sarcoma. Histopathology. 2003;43:220-230.
4. van de Rijn M, Barr FG, Xiong QB, et al. Poorly differentiated synovial sarcoma: An analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol. 1999;23:106-112.
5. Sreekantaiah C, Ladanyi M, Rodriguez E, et al. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol. 1994;144:1121-1134.
6. Skytting B, Nilsson G, Brodin B, et al. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst. 1999;91:974-975.
7. Mancuso T, Mezzelani A, Riva C, et al. Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma. Lab Invest. 2000;80:805-813.
8. van de Rijn M, Barr FG, Collins MH, et al. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. Am J Clin Pathol. 1999;112:43-49.
9. Poteat HT, Corson JM, Fletcher JA. Detection of chromosome 18 rearrangement in synovial sarcoma by fluorescence in situ hybridization. Cancer Genet Cytogenet. 1995;84:76-81.
10. Hiraga H, Nojima T, Abe S, et al. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors. Diagn Mol Pathol. 1998;7:102-110.
11. Coindre JM, Pelmus M, Hostein 1, et al. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases, Cancer. 2003;98:2700-2707.
12. Nolle M, Werner M, Ewig M, et al. Megakaryocytes carry the fused bcrabl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies. Virchows Arch, 1996;427: 561-565.
13. Cataldo KA, Jalal SM, Law ME, et al. Detection of t(2;5) in anaplastic large cell lymphoma: Comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol. 1999;23: 1386-1392.
14. Hasegawa SL, Davison JM, Rutten A, et al. Primary cutaneous Ewing's sarcoma: Immunophenotypic and molecular cytogenetic evaluation of five cases. Am J Surg Pathol. 1998;22:310-318.
15. Haralambieva E, Kleiverda K, Mason DY, et al. Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections. J Pathol. 2002;198:163-170.
16. Lee W, Han K, Harris CP, et al. Use of FISH to detect chromosomal translocations and deletions. Analysis of chromosome rearrangement in synovial sarcoma cells from paraffin-embedded specimens. Am J Pathol. 1993;143:15-19.
17. Shipley J, Crew J, Birdsall S, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol. 1996;148:559-567.
18. Zilmer M, Harris CP, Steiner DS, et al. Use of nonbreakpoint DNA probes to detect the t(X;18) in interphase cells from synovial sarcoma: Implications for detection of diagnostic tumor translocations. Am J Pathol. 1998;152:1171-1177.
19. Lu YJ, Birdsall S, Summersgill B, et al. Dual colour fluorescence in situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: A diagnostic and prognostic aid for synovial sarcoma. J Pathol. 1999;187:490-496.
20. Surace C, Panagopoulos J, Palsson E, et al. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma. Lab Invest. 2004;84:1185-1192.
21. Chang CC, Shidham VB. Molecular genetics of pediatric soft tissue tumors: clinical application. J Mol Diagn. 2003;5:143-154.
22. Chin SF, Daigo Y, Huang HE, et al. A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples. Mol Palhol. 2003;56:275-279.
23. Nielsen TO, Hsu FD, O'Connell JX, et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol. 2003;163:1449-1456.
24. Argani P, Zakowski MF, Klimstra DS, et al. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Palhol. 1998;11:65-71.
25. Florell SR, Schmidt SJ, Porter-Gill P, et al. Novel application of a fibrin cell block method to evaluate melanocytic cell populations. Pigment Cell Res. 2003;16:662-669.
26. Kawai A, Naito N, Yoshida A, et al Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett. 2004;204:105-113.
27. Sato Y, Nabeta Y, Tsukahara T, et al. Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma. J Immunol. 2002;169:1611-1618.
28. RPCI-11 Human Male BAC Library [database online]. Childrens Hospital Oakland Research Institute; 2004, Available at: http://bacpac.chori.org/hmale11. htm.
29. Fritsch MK, Bridge JA, Schuster AE, et al. Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue. Pediatr Dev Pathol. 2003;6:43-53.
30. Bijwaard KE, Fetsch JF, Przygodzki R, et al. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction. J Mol Diagn. 2002;4:59-64.
31. Gaffney R, Chakerian A, O'Connell JX, et al. Novel fluorescent ligase detection reaction and flow cytometric analysis of SYT-SSX fusions in synovial sarcoma. J Mol Diagn. 2003;5:127-135.
32. Hill DA, Riedley SE, Patel AR, et al. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: Report of 25 cases from St. Jude Children's Research Hospital. Pediatr Dev Pathol. 2003;6:24-34.
33. Krafft AE, Duncan BW, Bijwaard KE, et al. Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: The Armed Forces Institute of Pathology experience and literature review. Mol Diagn. 1997;2:217-230.
34. Fletcher CD, Fletcher JA, Cin PD, et al. Diagnostic gold standard for soft tissue tumours: Morphology or molecular genetics? Histopathology. 2001;39:100-103.
35. Ben-Ezra J, Johnson DA, Rossi J, et al. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem. 1991;39:351-354.
36. Diaz LK, Gupta R, Kidwai N, et al. The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer. J Histochem Cytochem. 2004;52:501-507.
37. Zaharieva BM, Simon R, Diener PA, et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol. 2003;201:603-608.
38. Hughes-Davies L, Huntsman D, Ruas M, et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell. 2003;115:523-535.
39. Makretsov N, He M, Hayes M, et al. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosomes Cancer. 2004;40:152-157.
40. Molenaar WM, DeJong B, Buist J, et al. Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest. 1989;60:266-274.
41. Storlazzi CT, Mertens F, Mandahl N, et al. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Genes Chromosomes Cancer. 2003;37:195-200.